Correlation Between Larimar Therapeutics and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Terns Pharmaceuticals, you can compare the effects of market volatilities on Larimar Therapeutics and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Terns Pharmaceuticals.
Diversification Opportunities for Larimar Therapeutics and Terns Pharmaceuticals
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Larimar and Terns is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Terns Pharmaceuticals
Given the investment horizon of 90 days Larimar Therapeutics is expected to under-perform the Terns Pharmaceuticals. In addition to that, Larimar Therapeutics is 1.8 times more volatile than Terns Pharmaceuticals. It trades about -0.14 of its total potential returns per unit of risk. Terns Pharmaceuticals is currently generating about -0.14 per unit of volatility. If you would invest 651.00 in Terns Pharmaceuticals on August 28, 2024 and sell it today you would lose (72.00) from holding Terns Pharmaceuticals or give up 11.06% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Larimar Therapeutics vs. Terns Pharmaceuticals
Performance |
Timeline |
Larimar Therapeutics |
Terns Pharmaceuticals |
Larimar Therapeutics and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Larimar Therapeutics and Terns Pharmaceuticals
The main advantage of trading using opposite Larimar Therapeutics and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |